[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”0px||||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.16″ _module_preset=”default” width_tablet=”” width_phone=”100%” width_last_edited=”on|tablet” max_width_tablet=”” max_width_phone=”100%” max_width_last_edited=”on|phone” custom_padding=”0px||||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_image src=”https://www.rsifertility.com/wp-content/uploads/2022/04/Pharmashots-Interview-RSI-Diana-Peninger-ProteX-Male-Fertility.webp” alt=”Pharmashots interviews Reproductive Solutions CEO Diana Peninger about ProteX, a new solution for Male Infertility” title_text=”Pharmashots-Interview-RSI-Diana-Peninger-ProteX-Male-Fertility” url=”https://pharmashots.com/7279/pharmashots-interview-reproductive-solutions%E2%80%99-diana-peninger-shares-insights-on-protex-a-solution-for-male-infertility” url_new_window=”on” _builder_version=”4.17.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][/et_pb_image][et_pb_text _builder_version=”4.16″ _dynamic_attributes=”content” _module_preset=”default” text_font=”|600||on|||||” text_text_color=”gcid-985809e8-7c80-41ed-b6e9-a286998ea041″ text_font_size=”18px” text_letter_spacing=”0.03em” text_line_height=”1.2em” custom_padding_tablet=”” custom_padding_phone=”|2em||2em|false|true” custom_padding_last_edited=”on|phone” text_font_size_tablet=”16px” text_font_size_phone=”14px” text_font_size_last_edited=”on|phone” global_colors_info=”{%22gcid-985809e8-7c80-41ed-b6e9-a286998ea041%22:%91%22text_text_color%22%93}” theme_builder_area=”post_content”]@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9kYXRlIiwic2V0dGluZ3MiOnsiYmVmb3JlIjoiIiwiYWZ0ZXIiOiIiLCJkYXRlX2Zvcm1hdCI6IkYgZCwgWSIsImN1c3RvbV9kYXRlX2Zvcm1hdCI6IiJ9fQ==@[/et_pb_text][et_pb_text _builder_version=”4.17.0″ _module_preset=”default” text_font=”|300|||||||” text_text_color=”#000000″ text_font_size=”21px” text_letter_spacing=”0.03em” text_line_height=”1.8em” custom_margin=”||0px||false|false” custom_padding_tablet=”” custom_padding_phone=”|2em||2em|false|true” custom_padding_last_edited=”on|phone” text_font_size_tablet=”19px” text_font_size_phone=”18px” text_font_size_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”]
PharmaShots asks Reproductive Solutions CEO, Diana Peninger, what makes ProteX so innovative and helpful for couples going through infertility. Learn what 48 hours of of semen sample stability means to both couples and clinics when they typically have only had 45-60 minutes. Plus, get a detailed introduction to the company driving more innovation in the male fertility space.
[/et_pb_text][et_pb_button button_url=”https://pharmashots.com/7279/pharmashots-interview-reproductive-solutions%E2%80%99-diana-peninger-shares-insights-on-protex-a-solution-for-male-infertility” url_new_window=”on” button_text=”Read the Article” button_alignment=”left” module_id=”blog-post-button” _builder_version=”4.17.0″ _module_preset=”46adfe3f-8800-40ca-81d3-8919197128e2″ button_text_size=”21px” button_rel=”off|off|on|off|off” custom_margin=”0px||||false|false” custom_margin_tablet=”0px||||false|false” custom_margin_phone=”|2em||2em|false|true” custom_margin_last_edited=”on|phone” custom_padding=”0.5em|2.5em|0.5em|2.5em|true|true” custom_padding_tablet=”|2em||2em|true|true” custom_padding_phone=”|1em||1em|true|true” custom_padding_last_edited=”on|desktop” button_text_size_tablet=”19px” button_text_size_phone=”18px” button_text_size_last_edited=”on|desktop” global_colors_info=”{}” theme_builder_area=”post_content”][/et_pb_button][/et_pb_column][/et_pb_row][/et_pb_section]